Neurogene Inc. · NASDAQ:NGNE

Cvijic Christine Mikail sold 4,800 Neurogene Inc. shares (Form 4)

Traded Jul 6 to Jul 7, 2026 · Filed Jul 7, 2026

From Jul 6 to Jul 7, 2026, Cvijic Christine Mikail (Director, President and CFO) sold 4,800 Neurogene Inc. shares at an average US$36.12 for US$173K under a trading plan, leaving 84,040 shares. Filed Jul 7, 2026 (Form 4).

Sold
4,800 shares
Price
US$36.12 average (US$36.02 to US$36.13)
Value
US$173K
Holding after
84,040 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, President and CFO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 6, 2026Common StockSale600US$36.0288,240Direct
Jul 7, 2026Common StockSale4,200US$36.1384,040Direct

Source

View original at SEC

Related